Small Molecules

05 Jun 2007 Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
05 Jun 2007 Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
05 Jun 2007 NPS Announces Progression of the Calcilytics Development Program in Osteoporosis by GlaxoSmithKline
05 Jun 2007 ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
04 Jun 2007 Tapestry Pharmaceuticals presents Phase I data on TPI 287 at the 43rd ASCO Annual Meeting
04 Jun 2007 Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
04 Jun 2007 Vical Demonstrates Safety and Tolerability of IL-2 DNA Delivery with Electroporation
04 Jun 2007 ARIAD Presents Positive Efficacy Data On AP23573, Novel mTOR Inhibitor, in Phase 2 Metastatic Endometrial Cancer Trial
04 Jun 2007 Positive data from ASA404 prostate cancer trial presented at ASCO
04 Jun 2007 Millennium Introduces New Oncology Molecule with Activity in Broad Range of Cancer Models
03 Jun 2007 ABRAXANE Demonstrates Longer Progression-Free Survival versus Taxotere in the Treatment of First-Line Metastatic Breast Cancer
03 Jun 2007 INNOVIVE Pharmaceuticals Presents Additional Phase I Data on INNO-406 for Treatment of Gleevec-Resistant or Intolerant Chronic Myelogenous Leukemia at the American Society of Clinical Oncology Annual Meeting
03 Jun 2007 Cyclacel reports Phase I sapacitabine data in patients with advanced leukemias and myelodysplastic syndromes at 2007 ASCO
03 Jun 2007 Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
03 Jun 2007 Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
03 Jun 2007 Exelixis Reports Comprehensive XL880 Phase I Data At ASCO
03 Jun 2007 Xanthus presents Phase 2 data showing Xanafide is associated with complete remissions in secondary AML
03 Jun 2007 Pharmion and MethylGene Report Preliminary Data for MGCD0103 at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting
03 Jun 2007 Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer
03 Jun 2007 ZIO-101 (Darinaparsin) Phase I Advanced Solid Tumor Data Presented at ASCO
03 Jun 2007 ZIO-101 (Darinaparsin) Early Interim Multiple Myeloma Phase I/II Data Presented at ASCO
03 Jun 2007 Data from ArQule's Phase 1 Trial with c-Met Inhibitor, ARQ 197, Demonstrate Safety and Expanded Anti-Cancer Activity
03 Jun 2007 Data Presented at ASCO Showed TORISEL Significantly Increased Quality-Adjusted Survival for Patients With Advanced Renal Cell Carcinoma
03 Jun 2007 Clinical Data Presented on Pilot Pharmacokinetic Study of Oral Azacitidine
03 Jun 2007 Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up